Tag Archives: biosimilar derivatives

EQT Future fund part of a consortium of investors acquiring a minority stake in drug delivery solutions provider SHL Medical

(PRESS RELEASE) STOCKHOLM, 9-Dec-2022 — /EuropaWire/ — EQT, a purpose-driven global investment organization, has announced that its EQT Future fund, the firm’s new impact-driven longer-hold investment strategy, is co-investing in the SHL Medical, a world-leading provider of drug delivery solutions. … Read the full press release